Abstract

The Administrative Core will serve all of the administrative needs of the Hep C Center programs. This will include ensuring regulatory compliance and budgetary oversight. This Core will coordinate all of the programs and will integrate the input of the Executive Committee. The Administrative Core will also be responsible for communicating with NIAID for the scientific and programmatic progress.

Public Health Relevance

ADMIN CORE NARRATIVE The Administrative Core will serve all of the administrative needs of the Hep C Center programs. This will include ensuring regulatory compliance and budgetary oversight. This Core will coordinate all of the programs and will integrate the input of the Executive Committee. The Administrative Core will also be responsible for communicating with NIAID for the scientific and programmatic progress.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI123862-01
Application #
9096396
Study Section
Special Emphasis Panel (ZAI1-MFH-M (J1))
Project Start
2016-04-01
Project End
2021-03-31
Budget Start
2016-04-01
Budget End
2017-03-31
Support Year
1
Fiscal Year
2016
Total Cost
$278,031
Indirect Cost
$62,031

  Institution

Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304

  Publications

Verrier, Eloi R; Yim, Seung-Ae; Heydmann, Laura et al. (2018) Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes. Hepatology 68:1695-1709
Ligat, Gaetan; Schuster, Catherine; Baumert, Thomas F (2018) HBV core variants, liver fibrosis and hepatocellular carcinoma. Hepatology :
Foung, Steven K H; Baumert, Thomas F (2018) Editorial: Current Progress and Challenges in the Development of a B Cell Based Hepatitis C Virus Vaccine. Front Immunol 9:2577
Keck, Mei-Le; Wrensch, Florian; Pierce, Brian G et al. (2018) Mapping Determinants of Virus Neutralization and Viral Escape for Rational Design of a Hepatitis C Virus Vaccine. Front Immunol 9:1194
Baumert, Thomas F; Berg, Thomas; Lim, Joseph K et al. (2018) Status of Direct-acting Antiviral Therapy for HCV Infection and Remaining Challenges. Gastroenterology :
Colpitts, Che C; Tawar, Rajiv G; Mailly, Laurent et al. (2018) Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape. Gut 67:736-745
Mesalam, Ahmed Atef; Desombere, Isabelle; Farhoudi, Ali et al. (2018) Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1. Virology 514:30-41
Wrensch, Florian; Crouchet, Emilie; Ligat, Gaetan et al. (2018) Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design. Front Immunol 9:1436
Colpitts, Che C; Baumert, Thomas F (2017) Claudins in viral infection: from entry to spread. Pflugers Arch 469:27-34
Khera, Tanvi; Todt, Daniel; Vercauteren, Koen et al. (2017) Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy. Antiviral Res 139:129-137

Showing the most recent 10 out of 26 publications